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Background/aim: The post-COVID-19 Functional Status (PCFS) has recently been developed for functional outcomes of COVID-19
upon discharge and in long term. The purpose of this study was to investigate the reliability and validity properties of the Turkish version
of the PCFS in Turkish post-COVID-19 patients with hospitalized and nonhospitalized during infection.
Materials and methods: One hundred participants with post-COVID-19 were included in this cross-sectional study. Test-retest
reliability of the Turkish version of PCFS assessed by intraclass correlation coefficient (ICC) and Cronbach’s alpha was calculated for
internal consistency. For construct validity, correlation coefficients between the Turkish version of PCFS developed by translation-back
translation method and modified Medical Research Council (mMRC) dyspnea scale (MMRC), London Chest Activities of Daily Living
(LCADL) scale, Barthel Index (BI) were analyzed.
Results: For test-retest reliability analysis, ICC ranged between 0.734 and 0.880. The total ICC score was 0.821, indicating excellent
reliability. The Cronbach’s alpha value of the PCFS test and retest scores were recorded as 0.821 indicating that the scale is quite reliable.
The PCFS score was moderately correlated with the mMRC score (r = 0.534, p < 0.001) and weakly correlated with the LCADL self care
(r = 0.311, p = 0.002), domestic (r = 0.277, p = 0.005), physical activity (r = 0.342, p < 0.001), leisure subscores (r = 0.434, p < 0.001)
and total score (r = 0.399, p < 0.001).
Conclusion: The Turkish version of the PCFS scale is reliable scale that reflects activity limitation and functional status after COVID-19.
The Turkish version of the PCFS will be a guide for rehabilitation professionals to understand functional limitation after COVID-19 and
to direct interventions accordingly to functional status of the patients at discharge and in long term.
Key words: Covid 19, SARS-CoV-2 infection, functional status, dyspnea, reliabilities, test-retest

1. Introduction
The new type of Coronavirus (SARS-CoV-2) pandemic puts
a great pressure on health systems around the world [1].
Coronavirus Disease 2019 (COVID-19) has a wide range of
clinical manifestations, ranging from an asymptomatic state
or mild respiratory symptoms to severe viral pneumonia
and acute respiratory distress syndrome (ARDS) [2].
The individuals who survived after ARDS were
reported to have significantly lower exercise capacity and
health status than the general population, even after two
years [3]. Persistent physical, cognitive and psychosocial
disorders can be seen in survivors of ARDS [1,3]. Vaes
et al. reported that patients recovered after COVID-19
have still persistent COVID-19-associated symptoms,
poor working capacity and health status, moderate-severe
functional limitations at 6 months follow-up [4].

Given the clinical heterogeneity of COVID-19 and
the large number of survivors of COVID-19 that require
follow-up, it is important to have a simple tool for the
disease to monitor the course of symptoms and the impact
of symptoms on patients’ functional status. Klok et al.
developed post-COVID-19 Functional Status (PCFS) scale
to assess functional status to capture the heterogeneity of
post-COVID-19 outcomes [5]. They reported that the
PCFS could be used after discharge at 4 and 8 weeks to
directly monitor recovery, and at 6 months to assess
functional sequelae. The PCFS scale could was designed
to be used as an additional outcome measure to evaluate
the final consequences of COVID-19 on functional status,
not to replace other relevant tools for measuring quality of
life, fatigue or dyspnea in the acute phase. The PCFS score
ranges between 0 and 5 in which 0 indicates no functional
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limitation and 5 indicates death [5]. The supporting
information such as a manual and various translations of
the PCFS scale are freely accessible via its website (https ://
osf.io/qgpdv /(CC-BY 4.0)).
However, only one study has investigated construct
validity of the PCFS scale in individuals with postCOVID-19 [6]. There is no valid and reliable and diseasespesific tool to evaluate functional status after COVID-19
in the Turkish population. Therefore, the aim of this study
is to investigate the test-retest reliability and construct
validity of the Turkish version of PCFS scale in Turkish
population. This tool will be a guide to understand
functional limitations of patients after COVID-19 and
ease selection of proper post-COVID-19 patients who
can benefit from rehabilitation at discharge and during
recovery period and to evaluate the efficacy of rehabilitation
interventions for rehabilitation professionals.
2. Materials and methods
The study was conducted between September 2020
and December 2020. The study was carried out at the
Cardiopulmonary Rehabilitation Unit of Faculty of
Physical Therapy and Rehabilitation, Hacettepe University.
The sample size of the study was determined as 5 times of
the number of items used in the scale [7]. We tried to reach
as many participants as possible to increase the strength of
the study.
2.1. Participants
The inclusion criteria for participants were being ≥ 18
years, having an education level at least primary school,
being a native Turkish speaker, being hospitalized or
nonhospitalized post-COVID-19 patients in recovery
period. The individuals who were hospitalized in the
intensive care unit (ICU), have severe neuromuscular and
musculoskeletal problems, have cognitive problems, who
are unable to cooperate, unable to read and write, and not
willing to participate were excluded. Hacettepe University
Non-Interventional Clinical Research Ethics Committee
approved the study on 01.09.2020, with the registration
number GO 20/788. All participants were informed
about the study protocol. This study was registered in
ClinicalTrials.gov: NCT04584450.
2.2. Translation and cultural adaptation
First of all, the permission to investigate the construct
validity and test-retest reliability of PCFS scale in the
Turkish population was obtained from the developer of the
PCFS scale. The PCFS scale was translated by two native
Turkish speakers who have a good command of English.
A common version was formed with the synthesis of the
two translations. Two independent native English speaker
proficient in Turkish who had not studied on the first
translation process performed retranslation (from Turkish
to English). The original and re-translated versions of the
PCFS scale were compared and reviewed by the expert

committee that consists three physiotherapists, and the
prefinal version was created. A pilot group of 30 patients
with post-COVID-19 assessed the understandability of the
scale and gave their inputs. After the pilot group assesments
completed, the final form of the PCFS scale was given by
the committee based on the findings [8].
2.3. Evaluations
The participants were asked to fill out an online form
using Google Forms. The physical characteristics, smoking
history, symptoms, comorbidities, the length of stay in
hospital and time since first COVID-19 diagnosis were
recorded. The diagnosis of COVID-19 was confirmed
based on reverse transcription polymerase chain reaction
(RT-PCR) test and/or computed tomography (CT) scan of
the thorax. For test-retest reliability, the questionnaire was
repeated twice at an interval of 7 days.
The PCFS scale stratifies functional status limitation
as follows: grade 0 (No functional limitations), grade
1 (Negligible functional limitations), grade 2 (Slight
functional limitations), grade 3 (Moderate functional
limitations), grade 4 (Severe functional limitations), and
grade 5 (death) [5].
Perceived functional limitations during daily life as a
result of dyspnea was assessed using the modified Medical
Research Council (mMRC) dyspnea scale. Individuals are
asked to choose the expression that best describes their
dyspnea level. The scoring in mMRC varies between 0–4
points. “0 points” means that there is no dyspnea, and
“4 points” indicates that there is a perception of dyspnea
during basic daily life activities such as dressing [9].
The Turkish version of the London Chest Activities
of Daily Living (LCADL) Scale was used to evaluate the
construct validity of the PCFS scale [10]. The LCADL
scale consists of 15 items and four components: self-care (4
items), domestic (6 items), physical activity (2 items), and
leisure (3 items). Each item is scored between 0 and 5. High
scores show that the limitation in daily living activities due
to dyspnea symptom is greater. The maximal score that can
be reached is 75 [10].
The Turkish version of the Barthel Index (BI) was also
used to the construct validity of the PCFS scale. This simple
and understandable BI consists of 10 subheadings: Feeding,
bathing, self-care, dressing, bladder control, bowel control,
toilet use, chair/bed transfer, mobility, use of stairs. The
total score ranges from 0 to 100. The higher score reflects a
greater ability to function independently following hospital
discharge. The BI score could be classified as follows: 0–20
indicates “total” dependency, 21–60 indicates “severe”
dependency, 61-90 indicates “moderate” dependency, and
91–99 indicates “slight” dependency [11].
2.4. Statistical analysis
The statistical analysis was performed using the SPSS for
Windows (Version 23.0, IBM Inc., Armonk, NY, USA).
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The data were expressed as mean±standard deviation (SD)
and minimum-maximum for quantitative variables and as
percentage (%) for categorical variables.
The construct validity of the PCFS scale was measured
using correlation coefficients between the Turkish version
of PCFS scale and mMRC dyspnea scale, LCADL scale, BI.
The internal consistency of the PCFS scale was assessed
using Cronbach’s α coefficient. A cronbach’s alpha value
0.60 ≤ α ≤ 0.79 is considered quite reliable and α ≥ 0.80
is considered highly reliable [12]. The test-retest reliability
was measured using the intraclass correlation coefficients
(ICC). ICC values ranges from 0.00 to 1.00, with values
of 0.60 to 0.80 demonstrates good reliability and ICC
values above 0.80 indicates excellent reliability [13]. The
relationships between the parameters were analyzed
assessed using Spearman’s rank correlation coefficients
accordingly to the normality. The correlation coefficient
was interpreted as little or no (0 to 0.25), weak (0.26 to
0.49), moderate (0.50 and 0.69), strong (0.70 and 0.89),
very strong (0.90 and 1.00) [14]. The probability of error
in the statistical analyses was determined as p < 0.05 [15].
3. Results
One hundred individuals (mean age = 36.6±13.8 years,
female/male = 59/41) were included in the study. The
physical characteristics, smoking status, symptoms,
comorbidities, and the length of stay in hospital were
shown in Table 1. Sixty percentage of post-COVID-19
patients were hospitalized (without admission to the
ICU), and 40% of patients were nonhospitalized during
infection period. Whereas, most of the post-COVID-19
patients (43%) reported no functional limitation, 31% of
patients had grade 1, 20% of patients had grade 2, and 6%
of patients had grade 3 functional limitation according to
PCFS.
3.1. Internal consistency and test-retest reliability
Internal consistency and test-retest reliability of the PCFS
scale were shown in Table 2. The Cronbach’s alpha value
of the PCFS test and retest scores were recorded as 0.821
indicating that the scale is highly reliable (Table 2). The ICC
values ranged from 0.734 to 0.880 (Table 2). According to
the mean ICC value, the PCFS test-retest reliability results
were excellent. The PCFS test score was also significantly
correlated with PCFS retest score (r = 0.707, p < 0.001,
Table 3).
3.2. Validity
The correlation coefficients between the PCFS score and
the criterion questionnaires are presented in Table 3. The
PCFS score was moderately correlated with the mMRC
dyspnea scale (r = 0.534, p < 0.001) and weakly correlated
with the LCADL self care (r = 0.311, p = 0.002), domestic
(r = 0.277, p = 0.005), physical activity (r = 0.342, p <
0.001), leisure subscores (r = 0.434, p < 0.001), and total
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score (r = 0.399, p < 0.001). There was not any association
between the scores of PCFS and BI (p>0.05, Table 3).
4. Discussion
This study demonstrated the Turkish version of PCFS is
reliable and has high internal consistency. The PCFS scale
has moderate relation with the functional status measures
that reflects activity limitation and daily physical activity
level.
To the best of our knowledge, there is no published
reliability and validity studies of the PCFS for any language
in the literature. The present study demonstrated that
the Turkish version of the PCFS scale has high internal
consistency level with Cronbach’s alpha value (0.821). This
shows us that the PCFS scores are stable over time despite
one week time interval between test and retest. We also
found high ICC values for test-retest reliability and strong
correlation between test and retest PCFS scores in our
study. An excellent level of reliability of the measuring tool
is a quality indicator for this tool. We think that the Turkish
version of the PCFS scale has a high level of reliability for
evaluating functional status after COVID-19 infection.
The developers of the PCFS scale reported that this scale
can be used for assessing functional status after discharge
and for long term functional results after COVID-19. They
also stated that the usefulness of the PCFS scale depends
on the local conditions [5]. Despite there is no published
reliability studies of the PCFS scale in any language, the
construct validity of the PCFS scale was demonstrated
very recently in highly-symptomatic post-COVID-19
patients three months after the onset of symptoms [6]. For
construct validity, we assessed the correlations between
the PCFS score and the scores of mMRC dyspnea scale,
LCADL and BI. We especially selected the mMRC dyspnea
and LCADL as indicators of activity limitation related with
dyspnea [16]. We used the BI as a measure of functional
performance in ADL [11]. We selected BI for construct
validity because BI was one of the most used assessment
tools for evaluating ADL in post-COVID-19 [17] and
BI also gives opportunity for assessing all parameters of
daily life activities [11]. We demonstrated the Spearman
correlation coefficient value of the PCFS score with the
mMRC dyspnea scale score was 0.534. Furthermore, the
PCFS score was weakly correlated with the LCADL self
care (r = 0.311), domestic (r = 0.277), physical activity (r
= 0.342), leisure subscores (r = 0.434) and total score (r
= 0.399). The most of post-COVID-19 patients (>70%)
with mean PCFS score (2.3±1.1 for hospitalized patients,
2.4±0.8 for non-hospitalized patients) were reported
to have dyspnea symptom 3 months after infection [4].
Another study confirmed that as the PCFS score increases,
there is gradual increase in presence and severity of
symptoms, decreased work productivity, daily usual
activities and poorer quality of life in post-COVID-19
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Table 1. The clinical characteristics of the participants.

Parameters

COVID-19 Survivors (n = 100)
Mean±SD

Min-Max

Age (years)

36.6 ± 13.8

18-82

Sex (female/male), n

59/41

Weight (kg)

69.8 ± 15.5

47–188

Height (cm)

168.9 ± 9.1

153–200

BMI (kg/m )

24.4 ± 4.5

11.5–37.2

Smoking (pack-years)

3.4 ± 7.6

0–35

n

%

Smoker

9

9

Ex-smoker

22

22

Non-smoker

69

69

Resting dyspnea

4

4

Effort dyspnea

58

58

PND

6

6

Ortopnea

8

8

Cough

20

20

Sputum

23

23

Literate

2

2

Primary school

5

5

Middle school

8

8

High school

21

21

University

49

49

Higher degree

15

15

Married

59

59

Single

36

36

Divorced

5

5

Unemployed

5

5

Student

14

14

Retired

11

11

Full time work

57

57

Part time work

3

3

Housewife

10

10

Median

Min-Max

mMRC dyspnea score (0-4)

1

0–3

CCI score

0

0–7

2

Smoking history

Symptom perceptions

Education level

Marital Status

Working Status
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Table 1. (Continued).
Mean±SD

Min-Max

Length of stay (days)

4.5 ± 7.0

0–54

Time since COVID-19 diagnosis (months)

2.7 ± 1.5

1–6

LCADL-self-care score

4.3 ± 1.0

2–9

LCADL-domestic score

6.1 ± 3.6

0–22

LCADL-physical activity score

2.9 ± 1.3

1–7

LCADL-leisure score

3.6 ± 1.2

2–9

LCADL-total score

17.0 ± 5.7

6–40

The degree dyspnea perception affects daily life in general

n

%

A lot/a little/not at all

7/45/48

7/45/48

Barthel ADL Index total score (0-100)

96.9 ± 12.2

0–100

Barthel functional classification

n

%

Independent

82

82

Slight dependency

12

12

Moderate dependency

4

4

Severe dependency

1

1

Total dependency

1

1

LCADL

Barthel ADL Index

Abbreviations: SD: standard deviation, BMI: Body Mass Index, CCI: Charlson Comorbidity Index,
mMRC: Modified Medical Research Council Dyspnea Scale, PND: Paroxysmal nocturnal dyspnea.
Table 2. The internal consistency and intraclass correlation (ICC) coefficients values of
the PCFS.

PCFS score
PCFS score

1st Test
Median (Min-Max)

2nd Test
Median (Min-Max)

1 (0–3)

1 (0–3)

Cronbach’s α

ICC

95% CI

0.821

0.821

0.734–0.880

Abbreviations: PCFS: Post-COVID-19 Functional Status Scale, ICC: Intraclass correlation
coefficient; CI: Confidence interval.

patients after three months [6]. We found that the Turkish
version of PCFS scale was moderately correlated with
the MMRC scale but weakly correlated with the LCADL
scale. The moderate association between the MMRC scale
score and the PCFS score can be related with that 58%
of post-COVID-19 patients have effort dyspnea during
daily life and both scale is a functional limitation grading
system [5]. The mMRC dyspnea was also shown to be a
predictor of low physical activity level [18]. The significant
relationship between the mMRC dyspnea and PCFS scales
can be a result of that the PCFS scale evaluates functional
limitations including changes in lifestyle, sports and social
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activities [5]. It is common aspect for both scales to reflect
limitations in physical activity and daily living activities.
This close relation also confirms the previous findings that
persistent dyspnea limits ADL during follow-up in postCOVID-19 patients [4, 6]. The PCFS scale also concerns
functional limitations related with the symptoms like
the dyspnoea, pain, fatigue, muscle weakness, memory
loss, depression, and anxiety related with the COVID-19
[5]. This weak correlation between the PCFS score and
LCADL total and subscores can be expected since the
LCADL scale is predominantly concerned with dyspnea,
whereas the PCFS scale investigates other symptoms such

ÇALIK KÜTÜKCÜ et al. / Turk J Med Sci
Table 3. The bivariate correlations between the PCFS score and
scores of the criterion scales.
COVID-19 Survivors
(n = 100)
Parameters

PCFS score
r

p

PCFS test-retest score

0.707

< 0.001*

mMRC dyspnea score (0–4)

0.534

< 0.001*

LCADL

0.311

0.002*

Self-care score

0.277

0.005*

Domestic score

0.342

< 0.001*

Physical activity score

0.434

< 0.001*

Leisure score

0.399

< 0.001*

Barthel Index total score (0–100)

0.095

0.348

Abbreviations: PCFS: Post-COVID-19 Functional Status Scale,
mMRC: Modified Medical Research Council Dyspnea Scale,
LCADL: London Chest Activity of Daily Life Scale.
*
p < 0.05, Spearman correlation analysis.

as pain, fatigue, and muscle weakness [7,10]. The BI is
generally used to assess functional limitation in daily life
especially due to neurological disorders [19]. The BI were
also used in respiratory diseases and can demonstrate the
functional effect of disease on daily living activities in
geriatric respiratory diseases [20]. Although the literature
showed that the BI could be able to determine ADL
limitation in 60% of individuals after COVID-19 [17], the
mean score was 90 after COVID-19 discharge in patients
without ventilation support during hospital [21]. The
need for help for personal care also significantly decreases
from discharge to 6 month follow-up in post-COVID-19
patients [4]. The mean BI score of our post-COVID-19
patients that mainly consist of patients followed at home
and hospital without ICU admission was also above 90, and
only two patients had severe or total dependency during

daily living activities. Otherwise, we think that the reason
for any association between the PCFS score and the BI total
score could be that the BI may have underestimated real
physical limitation for not considering dyspnea, fatigue,
pain, or depression/anxiety [11,19]. This index evaluates
only dependency and does not consider the effects of
symptoms on daily life activities, unlike the PCFS. So, this
could lead to any association between the two measures.
The main limitation of our study was that we didn’t
include patients with COVID-19 who required ICU
admission. This may lead to no association between the
PCFS score and BI total score because any participants
stated severe dependency (score 4) on the PCFS scale.
According to our knowledge, the strength of this study
is being the first study that investigates psychometric
properties of the Turkish version of the PCFS scale.
In conclusion, the Turkish version of the PostCOVID-19 Functional Status Scale with excellent
reliability can be used for evaluating functional status of
Turkish patients with post-COVID-19. This simple, useful
and inexpensive tool is also closely related with functional
status measures that evaluates the effect of dyspnea, which
is one of the main complaint of individuals with postCOVID-19 on activity limitation.
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